Participation at the IASLC 2022 WCLC World Conference on Lung Cancer

TRACEPIGEN participant Milena Cavic attended the World Lung Cancer Congress (WCLC22) organized by the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria, August 5-9, 2022. WCLC22 is traditionally the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology. The congress covered a variety of topics related to lung cancer research, early detection, screening, clinical management, clinical trials, drug updates, and smoking cessation, among others.  

 

At the congress, Milena Cavic presented an abstract “Current status, challenges and perspectives of lung cancer screening in low- and middle-income countries”, during a poster viewing session on August 7, 2022. The abstract highlighted that current literature data on the status of lung cancer screening in low- and middle-income countries is scarce, often opinion-based or relates to one specific country/region/project. The main aim of this interim report was to outline the current obstacles and perspectives of lung cancer screening in LMIC and to propose guidance, recommendations, and future research strategies. The abstract merited special attention and was selected for a press release during a daily congress highlights session with a 10-minute presentation held on August 7, 2022. Dr Cavic also participated at WCLC22 as the co-chair of the IASLC Diagnostics Working Group of the IASLC Early Detection and Screening Committee, during a Committee corner session held on August 8, 2022, Committee meeting held on August 7, 2022 and Screening Symposium held on August 5, 2022. Dr Cavic was a moderator of a session “ES20: Management of Lung Cancer in the Era of COVID-19 II” held on August 8, 2022. All these activities were very useful for the dissemination of TRACEPIGEN project results and networking with potential new collaborators.  

Like this article?

Leave a comment

Latest posts

Press

Participation at the IASLC 2022 WCLC World Conference on Lung Cancer

TRACEPIGEN participant Milena Cavic attended the World Lung Cancer Congress (WCLC22) organized by the International Association for the Study of Lung Cancer (IASLC) in Vienna, Austria, August 5-9, 2022. WCLC22 is traditionally the world’s largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology. The congress covered a

At the laboratory
Press

Visit to the UCL Cancer Institute

As part of the TRACEPIGEN project, Dr Ivana Boljević spent two weeks in July on a short-stay secondment at UCL Cancer Institute, Department of Cancer Biology, Medical Genomics group (London, UK). She was hosted by Prof Stephan Beck and Dr Nnenna Kannu. During this period, she gained insights into the ongoing projects at the UCL,

Lungs with cancerous changes floating inside jar with formaldehyde in morgue
Press

Lung cancer in Serbia

Lung cancer in Serbia Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with the Institute for Pulmonary Diseases of Vojvodina and the Pulmonary Diseases Clinic, University Clinical Center Nis have provided an up-to-date overview of the current epidemiological situation concerning lung cancer in Serbia published by Cavic et al.

Press

The right tool for the job: Benchmarking kits for DNA methylome analysis

Scientists at IORS, supported by the Science Fund of the Republic of Serbia, in collaboration with Beck lab at UCL Cancer Institute have performed a systematic benchmarking of sequencing-based methods for measuring DNA methylation and developed a framework for data integration across different platforms in a paper published by Tanić et al. in Nature Biotechnology. Epigenetics

Press

Liquid Biopsy Training School

Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) was held on March 28-30, 2022, at Aarhus University Hospital in Denmark. It was co-organized by TRANSCOLONCAN COST Action together with DCCC Danish Research Center for ctDNA, TRACEPIGEN (Science Fund of the Republic of Serbia), and the European Liquid Biopsies Academy- ELBA. TRACEPIGEN

Liquid Biopsy Workshop

Training the new generation of scientists in the hot topic of liquid biopsy biomarkers. TRACEPIGEN project will co-organize the Training school for circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) in collaboration with COST Action TRANSCOLONCAN, the European Liquid Biopsy Academy, and the Danish National Research Center for ctDNA. The workshop will take place

Scroll to Top